Novo Nordisk CEO Mike Doustdar said on Monday as many as 1.5 million patients in the U.S. may be using compounded versions of ...

By Maggie Fick, Mrinalika Roy and Sabrina ValleSAN FRANCISCO, Jan 12 (Reuters) - Oral weight-loss drugs could account for a ...

Wegovy pill introduction in the U.S. may serve as the turning point that transforms a beleaguered GLP‑1 leader into a viable ...

Novo Nordisk executive Dave Moore touted high interest in Wegovy's oral version of its injectable GLP-1 weight-loss ...

Amazon Pharmacy said on Friday it now offers Novo Nordisk's Wegovy weight-loss pill through insurance plans as well as ...

The general mood among these heavyweight investors is divided, with 35% leaning bullish and 37% bearish. Among these notable options, 12 are puts, totaling $1,065,123, and 33 are calls, amounting to ...

In the last week of December, while most of the U.S. was still in holiday mode, Novo Nordisk’s plant in North Carolina was ...

Novo Nordisk's Wegovy pill is now available, providing those seeking help with their weight a GLP-1 medicine in a pill for ...

Novo took its message to the people by setting up an exhibit at New York’s Grand Central Terminal. In a major thoroughfare at ...

Novo Nordisk has launched its first oral GLP-1 weight-loss pill in the United States, expanding beyond injectable treatments ...

Aleksandar Ivanovic, UBS’ asset management boss is being touted as Ermotti’s potential successor." In Copenhagen, Novo ...

Wegovy’s oral version of its injectable weight-loss drug is seeing tremendous interest, Novo Nordisk executive Dave Moore ...